Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle

Iwahashi,Masaaki; Muragaki,Yasuteru; Ikoma,Makoto; Mabuchi,Yasushi; Kobayashi,Aya; Tanizaki,Yuuko; Ino,Kazuhiko

doi:10.3892/etm.2011.186

Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle

Authors:
- Masaaki Iwahashi
- Yasuteru Muragaki
- Makoto Ikoma
- Yasushi Mabuchi
- Aya Kobayashi
- Yuuko Tanizaki
- Kazuhiko Ino
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-0012, Japan, Department of Pathology, Wakayama Medical University, Wakayama 641-0012, Japan
Published online on: January 5, 2011 https://doi.org/10.3892/etm.2011.186
Pages: 287-290

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To investigate the possible involvement of collagen in the characteristic features of human leiomyoma, type I, III and IV collagen expression was determined at the protein level in normal myometrium and leiomyoma tissues throughout the menstrual cycle. The tissues were obtained from 40 pre-menopausal women (29-53 years of age) at various stages of the menstrual cycle who were undergoing abdominal hysterectomy for symptomatic uterine leiomyoma. Immunohistochemical staining was performed with specific monoclonal antibodies against type I, III and IV collagen in the leiomyoma and the myometrial tissues. Immunohistochemical analysis revealed that type I collagen expression was increased in the leiomyoma tissues at the protein level as compared to that in the normal myometrium tissues throughout the menstrual cycle. These results suggest that increased expression of type I collagen plays a key role in the pathogenesis of uterine leiomyoma.

View Figures

View References

1.	Lin CQ and Bissell MJ: Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7:737–743. 1993.PubMed/NCBI
2.	Madri JA and Basson MD: Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function. Lab Invest. 66:519–521. 1992.PubMed/NCBI
3.	Haralson MA: Extracellular matrix and growth factors: an integrated interplay controlling tissue repair and progression to disease. Lab Invest. 69:369–372. 1993.PubMed/NCBI
4.	Ferency A, Richart RM and Okazaki T: A comparative ultra-structural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus. Cancer. 28:1004–1018. 1971. View Article : Google Scholar : PubMed/NCBI
5.	Srewart AE, Friedman AJ, Peck K and Nowak RA: Relative overexpression of collagen type I and collagen III messenger ribonucleic acids by uterine leiomyoma during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 79:900–906. 1994.
6.	Catherino WH, Leppert PC, Stenmark MH, et al: Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer. 40:204–217. 2004. View Article : Google Scholar : PubMed/NCBI
7.	Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S and Segars JH: Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril. 82(Suppl 3): 1182–1187. 2004. View Article : Google Scholar : PubMed/NCBI
8.	Chavez NF and Stewart EA: Medical treatment of uterine fibroids. Clin Obstet Gynecol. 44:372–384. 2001. View Article : Google Scholar : PubMed/NCBI
9.	Ooshima A and Muragaki Y: Collagen metabolism in atherogenesis. Ann NY Acad Sci. 598:582–584. 1990. View Article : Google Scholar : PubMed/NCBI
10.	Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
11.	McCullagh KA and Balian G: Collagen characterisation and cell transformation in human atherosclerosis. Nature. 258:73–75. 1975. View Article : Google Scholar : PubMed/NCBI
12.	Ooshima A: Collagen α B chain: increased proportion in human atherosclerosis. Science. 213:666–668. 1981.
13.	Ishimura E, Sterzel RB, Budde K and Kashgarian M: Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol. 134:843–855. 1989.PubMed/NCBI
14.	Worthuis A, Boes A and Grond J: Cell density modulates growth, extracellular matrix, and protein synthesis of cultured rat mesangial cells. Am J Pathol. 143:1209–1219. 1993.PubMed/NCBI
15.	Patton WF, Yoon MU, Alexander JS, et al: Expression of simple epithelial cytokeratins in bovine pulmonary microvascular endothelial cells. J Cell Physiol. 143:140–149. 1990. View Article : Google Scholar : PubMed/NCBI
16.	Orpana A, Ranta V, Mikkola T, Viinikka L and Ylikorkala O: Inducible nitric oxide and prostacyclin productions are differently controlled by extracellular matrix and cell density in human vascular endothelial cells. J Cell Biochem. 64:538–546. 1997. View Article : Google Scholar
17.	Goodman LV and Majack RA: Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture. J Biol Chem. 264:5241–5244. 1989.
18.	Kato S, Shanley JR and Fox JC: Serum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. Am J Pathol. 149:687–697. 1996.PubMed/NCBI
19.	Ellis IR and Schor SL: Differential effects of TGF-beta 1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing. Exp Cell Res. 228:326–333. 1996. View Article : Google Scholar : PubMed/NCBI
20.	Brenn T, Aoyama T, Francke U and Furthmayr H: Dermal fibroblast culture as a model system for studies of fibrillin assembly and pathogenetic mechanisms: defects in distinct groups of individuals with Marfan's syndrome. Lab Invest. 75:389–402. 1996.PubMed/NCBI
21.	Tsonis PA and Goetinck PK: Cell density effects of a tumor promotor on proliferation and chondrogenesis of limb bud mesenchymal cells. Exp Cell Res. 190:247–253. 1990. View Article : Google Scholar : PubMed/NCBI
22.	Tang XM, Dou Q, Zhao Y, McLean F, Davis J and Chegini N: The expression of transforming growth factor-beta and TGF-beta receptor mRNA and protein and the effect of TGF-beta on human myometrial smooth muscle cells in vitro. Mol Hum Reprod. 3:233–240. 1997. View Article : Google Scholar : PubMed/NCBI
23.	Lee BS and Nowak RA: Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab. 86:913–920. 2001.PubMed/NCBI
24.	Sozen I and Arici A: Interactions of cytokines, growth factors, and extracellular matrix in the cellular biology of uterine leiomyoma. Fertil Steril. 78:1–12. 2002. View Article : Google Scholar : PubMed/NCBI
25.	Stein CA, Wu S, Voskresenskiy AM, et al: G3139, an anti-BCL-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis. Clin Cancer Res. 15:2797–2807. 2009. View Article : Google Scholar : PubMed/NCBI
26.	Hubchak SC, Sparks EE, Hayashida T and Schnaper W: Rac1 promotes TGF-β-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism. Am J Physiol Renal Physiol. 297:F1316–F1323. 2009.
27.	Barkan D, El Touny LH, Michalowski AM, et al: Metastatic growth from dormant cells induced by a Col-I-enriched fibrotic environment. Cancer Res. 70:5706–5716. 2010. View Article : Google Scholar : PubMed/NCBI
28.	Moore AB, Yu L, Swartz CD, et al: Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture. Cell Commun Signal. 8:102010. View Article : Google Scholar : PubMed/NCBI